Adherence to clinical guidelines in the prevention of coronary heart disease in type ii diabetes mellitus

M. Kamyar, B. Julienne Johnson, J.J. McAnaw, R. Lemmens-Gruber, S.A. Hudson

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The study aimed to assess adherence of prescribed medication in primary care to nationally recognised guideline criteria using case note review applying a previously developed medication assessment tool for coronary heart disease (MAT-CHD). Setting Primary care medical centre serving 17,991 patients. A sample of 208 from 463 patients with type 2 diabetes aged 20-75 years with or without a history of ischaemic heart disease (IHD). Method Patients' records were accessed via medical and pharmacy databases. The criteria of the 23-item audit tool were applied to medical records from case notes in order to quantify adherence to individual guideline criteria. Main outcome measure Frequency of adherence to agreed definitions of medication use quality criteria. Results A total of 1,433 guideline criteria were applied and 1,107 (77.2%, CI: 75.0, 79.4) criteria standards were met with 326 (22.7%, CI: 20.6, 25.0) non-adherences. The overall adherence to guideline criteria was significantly lower for secondary prevention than for primary prevention (74.4 vs. 80.1%, P < 0.05; Chi square). Justification recorded in the case notes was identified for 54 (17%, CI: 13, 21) of those non-adherences. Conclusion The MAT-CHD highlighted areas for review and possible improvement. The tool can be used in primary care from case record examination and offers a means of co-operation between community pharmacists and general practitioners in clinical guideline implementation.
LanguageEnglish
Pages120-127
Number of pages8
JournalPharmacy World and Science
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Medical problems
Type 2 Diabetes Mellitus
Coronary Disease
Guidelines
Primary Health Care
Guideline Adherence
Medication Adherence
Primary Prevention
Secondary Prevention
Health care
Pharmacists
General Practitioners
Medical Records
Myocardial Ischemia
Outcome Assessment (Health Care)
Databases

Keywords

  • cardiovascular disease
  • clinical guideline
  • community pharmacy
  • diabetes mellitus
  • primary prevention
  • public health
  • Scotland
  • secondary prevention

Cite this

Kamyar, M. ; Johnson, B. Julienne ; McAnaw, J.J. ; Lemmens-Gruber, R. ; Hudson, S.A. / Adherence to clinical guidelines in the prevention of coronary heart disease in type ii diabetes mellitus. In: Pharmacy World and Science. 2008 ; Vol. 30, No. 1. pp. 120-127.
@article{940f52ca2f6247e0a011deb5ca89daf5,
title = "Adherence to clinical guidelines in the prevention of coronary heart disease in type ii diabetes mellitus",
abstract = "The study aimed to assess adherence of prescribed medication in primary care to nationally recognised guideline criteria using case note review applying a previously developed medication assessment tool for coronary heart disease (MAT-CHD). Setting Primary care medical centre serving 17,991 patients. A sample of 208 from 463 patients with type 2 diabetes aged 20-75 years with or without a history of ischaemic heart disease (IHD). Method Patients' records were accessed via medical and pharmacy databases. The criteria of the 23-item audit tool were applied to medical records from case notes in order to quantify adherence to individual guideline criteria. Main outcome measure Frequency of adherence to agreed definitions of medication use quality criteria. Results A total of 1,433 guideline criteria were applied and 1,107 (77.2{\%}, CI: 75.0, 79.4) criteria standards were met with 326 (22.7{\%}, CI: 20.6, 25.0) non-adherences. The overall adherence to guideline criteria was significantly lower for secondary prevention than for primary prevention (74.4 vs. 80.1{\%}, P < 0.05; Chi square). Justification recorded in the case notes was identified for 54 (17{\%}, CI: 13, 21) of those non-adherences. Conclusion The MAT-CHD highlighted areas for review and possible improvement. The tool can be used in primary care from case record examination and offers a means of co-operation between community pharmacists and general practitioners in clinical guideline implementation.",
keywords = "cardiovascular disease, clinical guideline, community pharmacy, diabetes mellitus, primary prevention, public health, Scotland, secondary prevention",
author = "M. Kamyar and Johnson, {B. Julienne} and J.J. McAnaw and R. Lemmens-Gruber and S.A. Hudson",
year = "2008",
month = "1",
doi = "10.1007/s11096-007-9154-7",
language = "English",
volume = "30",
pages = "120--127",
journal = "Pharmacy World and Science",
issn = "0928-1231",
number = "1",

}

Adherence to clinical guidelines in the prevention of coronary heart disease in type ii diabetes mellitus. / Kamyar, M.; Johnson, B. Julienne; McAnaw, J.J.; Lemmens-Gruber, R.; Hudson, S.A.

In: Pharmacy World and Science, Vol. 30, No. 1, 01.2008, p. 120-127.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adherence to clinical guidelines in the prevention of coronary heart disease in type ii diabetes mellitus

AU - Kamyar, M.

AU - Johnson, B. Julienne

AU - McAnaw, J.J.

AU - Lemmens-Gruber, R.

AU - Hudson, S.A.

PY - 2008/1

Y1 - 2008/1

N2 - The study aimed to assess adherence of prescribed medication in primary care to nationally recognised guideline criteria using case note review applying a previously developed medication assessment tool for coronary heart disease (MAT-CHD). Setting Primary care medical centre serving 17,991 patients. A sample of 208 from 463 patients with type 2 diabetes aged 20-75 years with or without a history of ischaemic heart disease (IHD). Method Patients' records were accessed via medical and pharmacy databases. The criteria of the 23-item audit tool were applied to medical records from case notes in order to quantify adherence to individual guideline criteria. Main outcome measure Frequency of adherence to agreed definitions of medication use quality criteria. Results A total of 1,433 guideline criteria were applied and 1,107 (77.2%, CI: 75.0, 79.4) criteria standards were met with 326 (22.7%, CI: 20.6, 25.0) non-adherences. The overall adherence to guideline criteria was significantly lower for secondary prevention than for primary prevention (74.4 vs. 80.1%, P < 0.05; Chi square). Justification recorded in the case notes was identified for 54 (17%, CI: 13, 21) of those non-adherences. Conclusion The MAT-CHD highlighted areas for review and possible improvement. The tool can be used in primary care from case record examination and offers a means of co-operation between community pharmacists and general practitioners in clinical guideline implementation.

AB - The study aimed to assess adherence of prescribed medication in primary care to nationally recognised guideline criteria using case note review applying a previously developed medication assessment tool for coronary heart disease (MAT-CHD). Setting Primary care medical centre serving 17,991 patients. A sample of 208 from 463 patients with type 2 diabetes aged 20-75 years with or without a history of ischaemic heart disease (IHD). Method Patients' records were accessed via medical and pharmacy databases. The criteria of the 23-item audit tool were applied to medical records from case notes in order to quantify adherence to individual guideline criteria. Main outcome measure Frequency of adherence to agreed definitions of medication use quality criteria. Results A total of 1,433 guideline criteria were applied and 1,107 (77.2%, CI: 75.0, 79.4) criteria standards were met with 326 (22.7%, CI: 20.6, 25.0) non-adherences. The overall adherence to guideline criteria was significantly lower for secondary prevention than for primary prevention (74.4 vs. 80.1%, P < 0.05; Chi square). Justification recorded in the case notes was identified for 54 (17%, CI: 13, 21) of those non-adherences. Conclusion The MAT-CHD highlighted areas for review and possible improvement. The tool can be used in primary care from case record examination and offers a means of co-operation between community pharmacists and general practitioners in clinical guideline implementation.

KW - cardiovascular disease

KW - clinical guideline

KW - community pharmacy

KW - diabetes mellitus

KW - primary prevention

KW - public health

KW - Scotland

KW - secondary prevention

U2 - 10.1007/s11096-007-9154-7

DO - 10.1007/s11096-007-9154-7

M3 - Article

VL - 30

SP - 120

EP - 127

JO - Pharmacy World and Science

T2 - Pharmacy World and Science

JF - Pharmacy World and Science

SN - 0928-1231

IS - 1

ER -